A Study to Evaluate the Effectiveness of Autogenic Drainage and Postural Drainage for Improving Pulmonary Functions in Patients with Stable Chronic Obstructive Pulmonary Diseases by Janaki, M
A STUDY TO EVALUATE THE EFFECTIVENESS OF 
AUTOGENIC DRAINAGE AND POSTURAL DRAINAGE 
FOR IMPROVING PULMONARY FUNCTIONS IN 
PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE 
PULMONARY DISEASES 
 
 
 
 
 
 
 
 
 
 
 
DESSERTATION SUBMITTED TO  
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY  
 
TOWARDS PARTIAL FULFILLMENT AS A REQUIREMENT FOR THE 
DEGREE  
 
 
 
MASTER OF PHYSIOTHERAPY 
(PHYSIOTHERAPY IN CARDIO RESPIRATORY) 
 
 
 
 
APRIL – 2016 
 
 
 
A STUDY TO EVALUATE THE EFFECTIVENESS OF 
AUTOGENIC DRAINAGE AND POSTURAL DRAINAGE 
ON PULMONARY FUNCTIONS IN PATIENTS WITH 
STABLE CHRONIC OBSTRUCTIVE PULMONARY 
DISEASES 
. 
 
 
 
Internal Examiner: 
 
 
 
External Examiner: 
 
 
 
 
A dissertation submitted in partial fulfillment 
as a requirement for the degree  
 
 
MASTER OF PHYSIOTHERAPY 
To 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI 
APRIL 2016 
 
CERTIFICATE  
 
This is to certify that the research work entitled “A STUDY TO 
EVALUATE THE EFFECTIVENESS OF AUTOGENIC DRAINAGE 
AND POSTURAL DRAINAGE ON PULMONARY FUNCTIONS IN 
PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE 
PULMONARY DISEASES” was carried out by the candidate with the 
(REG NO: 271430141) Master of physiotherapy student at Thanthai Roever 
Collage of Physiotherapy,  Perambalur, submitted  to Tamil Nadu Dr. 
M.G.R. Medical University, Chennai towards the partial fulfillment as a 
requirement for the Degree Master of Physiotherapy (MPT- CARDIO 
RESPIRATORY). 
        
                                        
 
 
 
 
                         Prof. C.V. John Franklin, MPT., MIAP., 
                              Principal 
                                 Thanthai Roever College of Physiotherapy 
                                                   Perambalur -621212  
PLACE:   
DATE: 
 
 
 
CERTIFICATE 
  
This is to certify that the research work entitled “A STUDY TO 
EVALUATE THE EFFECTIVENESS OF AUTOGENIC DRAINAGE 
AND POSTURAL DRAINAGE ON PULMONARY FUNCTIONS IN 
PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE 
PULMONARY DISEASES” was carried out by the candidate with the 
(REG NO: 271430141)  Thanthai Roever College of Physiotherapy 
Perambalur under the guidance of me towards the partial fulfillment as a 
requirement for the degree Master of Physiotherapy Submitted to The 
TamilNadu Dr. MGR Medical University Chennai. (MPT- - CARDIO 
RESPIRATORY). 
 
 
 
 
 
GUIDE:    Prof. Muruganandam M.P.T (Cardio Respiratory)             
     Thanthai Roever College of Physiotherapy 
                                                 Perambalur -621212 
 
PLACE:                  
            
 DATE:                
 
ACKNOWLEDGEMENT 
 
 First and foremost I wish to acknowledge my heartfelt gratitude to 
the LORD ALMIGHTY for his presence and guidance. 
 My warm-hearted thanks to the Thanthai Roever College of 
Physiotherapy, St. John Sangam Trust, especially to the Chairman                  
Dr. K. VARADHARAJAN, B.A., B.L., FOR giving me an opportunity 
to study in this Institution. 
 I am indebted to Prof.  C.V. John Franklin, MPT., MIAP., 
Principal who spared his time and effort without his skilled knowledge, 
performance guidance and benevolence this research work would never 
have been finished. 
 I owe my sincere thanks to my Guide, Prof. P. Muruganandam, 
MPT Associate Professor Thanthai Roever College of Physiotherapy for 
his advice and assistance at different stages of this study. 
 I pay my thanks to my Faculty Members and their support and 
guidance.                                          
         
TABLE OF CONTENTS 
 
 
S. No 
 
Table of Content 
 
Page. No 
 
1 
 
INTRODUCTION 
 
1 
 
2 
 
NEED OF STUDY 
 
4 
 
3 
 
AIM & OBJECTIVES 
 
5 
 
4 
 
REVIEW OF LITERATURE 
 
6 
 
5 
 
DESIGN & METHODOLOGY 
 
9 
 
6 
 
DATA ANALYSIS & INTERPRETATION 
 
26 
 
7 
 
RESULT 
 
47 
 
8 
 
DISCUSSION 
 
48 
 
9 
 
CONCLUSION 
 
50 
 
10 
 
LIMITATION 
 
51 
 
11 
 
REFERENCE 
 
52 
 
12 
 
APPENDIX 
 
55 
 
 1 
INTRODUCTION 
 
Chronic Obstructive Pulmonary Disorder is a slow progressive 
disorder of the airways that is characterized by gradual loss of lung 
function. This results in lung destruction due to chronic mucus 
impartion and infection of airway. Clearance of this mucus is an 
important part of therapy in COPD but is complicated by impaired 
mucociliary clearance. The term COPD includes chronic bronchitis, 
chronic Obstructive bronchitis, emphysema or combinations of these 
conditions, as per National Heart Lung and Blood Institute, represents 
the fourth leading cause of death in the world.1  
  
 The pathological changes that occur over time in COPD are 
inflammation of the mucus membranes of the airways; decreased 
production and retention of mucus; narrowing and destruction of 
airways and bronchial walls. These structural changes are reflected in 
pulmonary function tests. Much physical impairment develops over 
time. Patients typically have a chronic, productive cough and are often 
short of breath. There is inability to remove air from the lungs which in 
turn affects the ability of the respiratory system to transport oxygen 
into the lungs. Consequently, functional limitations and eventually 
disability occur consistent with the disablement process. Impairments 
such as decreased vital capacity and forced expiratory volume are 
associated with decreased tolerance to exercise, frequent episodes of 
dysponea, decreased walking speed and distance and eventually 
inability to perform activities of daily living at home or in the work 
place or to remain an active participation in the community.2  
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 The purpose of this study was to determine the effectiveness of 
postural drainage and Autogenic Drainage on pulmonary function by 
mucus clearance techniques, because mucus clearance is a problem in 
COPD and Autogenic Drainage and Postural Drainage is a traditional 
method of facilitating mucus clearance. Research studies with COPD 
patients support the efficacy of Autogenic Drainage and Postural 
Drainage in patients who can tolerate it. Both these techniques promote 
independence and self-care in the patients and effectiveness of both has 
been supported by the researches.  
    
 Conventional therapy involves enhanced mucus clearance with 
Autogenic Drainage and Postural Drainage. Autogenic Drainage is an 
airway clearance that allows patients to do their own therapy. This 
provides more independence and control over daily care when 
compared with Postural Drainage. Autogenic Drainage was devised by 
the Belgian physiotherapists Jean chevalier. It was first developed in 
1960’s to treat Asthmatic patients. It is now being used widespread to 
treat patients with retention of secretions.3 
 
 Autogenic Drainage uses diaphragmatic breathing to mobilize 
secretions by varying expiratory airflow. It consists of these phases: 
a. Breathing at low lung volumes to ‘unstick’ the peripheral 
secretions. 
b. Breathing at low – to – mid lung volume (tidal volume) to 
‘collect’ mucus in   the middle airways. 
c. Breathing at mid – to – high lung volumes to ‘evacuate’ the 
mucus from the central airways.4 
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Postural Drainage is a component of bronchial hygiene therapy. 
It is accomplished by positioning the patient so that position of the 
lung segment to be drained allows gravity to have its greatest effect. 
The length of the time spent in each position and total treatment time 
will depend on the gravity of secretion in each area and the number of 
areas that have to be drained. It may be necessary to spend an average 
of 15 – 20 minutes in each position to allow adequate drainage and this 
may mean that different areas will require draining at alternate 
treatments. The worst areas would be drained first.4 Both of these 
techniques are used to improve forced vital capacity (FVC) and forced 
expiratory volume in one second (FEV1) which is analyzed by 
computerized spirometer. Spirometry is the pulmonary function test 
done to measure how much and how quickly you can move air out of 
your lungs. The test reveals the capacity of air it can hold, speed of 
breathing and ability to exchange gases from blood. The test can 
diagnose lung disease and measure the severity of lung problems. 
 
So, the importance of doing this study is that as we have come to 
know that COPD is characterized by a reduction in airflow and an 
increase in dead space & chronic cough and sputum production are 
common features of COPD and have significant impact on 
exacerbation frequency and quality of life. So, to increase Tidal 
Volume, decrease Respiratory Rate & sense of dysponea, postural 
drainage and autogenic drainage has been used for improving the 
quality of life and leading an independent life for the patient suffering 
from COPD. 
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NEED FOR THE STUDY 
 
To identify an effective technique for airway clearance and to improve 
pulmonary function. Because some studies says autogenic drainage is the one 
best for clear the secretion and other some says postural drainage is best. 
 
 
HYPOTHESIS 
Null hypothesis 
There is no significant difference between autogenic drainage and 
postural drainage in stable COPD patients. 
Alternate hypothesis 
There is significant difference between autogenic drainage and postural 
drainage in stable COPD patients. 
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AIM & OBJECTIVES 
 
 
 
AIM: 
 
 To identify an effective technique for airway clearance and to 
improve pulmonary function. 
 
 
OBJECTIVES: 
 
1. To compare the pulmonary function tests between the Autogenic 
Drainage and Postural Drainage. 
 
2. To find out the effectiveness of Autogenic Drainage and 
Postural Drainage in airway clearance. 
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REVIEW OF LITERATURE 
 
Holland AE et al., (2006) in his study quoted that chronic cough and 
sputum production are common features of chronic obstructive 
pulmonary disease. So, analysis of short – term studies suggested that 
there may be benefit from autogenic drainage which has proved 
positive result in clearance of sputum.7 
 
Pryor et al (2004) quoted that physical therapy techniques can be used 
to augment mucociliary clearance, for example the ACBT, autogenic 
drainage, positive expiratory pressure and there is a benefit from 
physical therapy for people with obstructive airway disease.10 
 
Opdekamp C et al., (2003) quoted that due to reduction in airflow and 
an increase in dead space in COPD patients. Postural drainage in most 
parts of the world has been used for airway clearance which also 
includes forced expiratory maneuvers or techniques of breathing at 
different airflow and lung volumes.8 
 
Savei S et al., (2000) in his study stated that Autogenic drainage has 
improved forced vital capacity, force expiratory volume in 1 second, 
peak expiratory flow rate, forced expiratory volume from 25 to 75% an 
concluded it by stating that Autogenic drainage is as effective as the 
ACBT in clearing secretions and improving lung functions.5  
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Langenderfer B (1998) in his study stated that percussion and postural 
drainage promotes independence and self care in the patients and these 
2 techniques are the traditional method of facilitating mucus 
clearance.6 
 
Donald R Giles (1995) in his study suggested that autogenic drainage 
and postural drainage has short term benefits in patients with cystic 
fibrosis but in pulmonary function test autogenic drainage is superior 
to postural drainage as a secretion clearance technique.9 
 
Olseni et al (1994) stated that 2 techniques, postural drainage and 
positive expiratory pressure breathing, were used. Both techniques 
were given with the combination of forced expiratory techniques. The 
outcome was the clearance of mucus was more effectively done by 
postural drainage combined with forced expiratory techniques.11 
 
Mortensen J et al., (1991) studied the effect of two chest 
physiotherapy regimens on whole lung and regional tracheobronchial 
clearance in 10 patients with cystic fibrosis. The regimen were given 
on 2 separate days and consisted of 20 min of (1) Postural drainage and 
the forced expiratory technique (PD + FET), and (2) Positive 
expiratory pressure (PEP – mask) and FET (PEP + FET). A third day 
served as control and he concluded that PD has short term whole lung 
and regional TBC in patients with cystic fibrosis.12 
 
 
 
 
 8 
 
Maloney FP et al., (1981) determined the effect of PD on pulmonary 
functions and sputum volume in patients with partially reversible 
chronic obstructive pulmonary disease; comparisons were made 
between days with and without PD in 13 patients. Pulmonary function 
tests were done 3 times a day over 12 – day period. Outcome was PD 
showed effect in some patients.13 
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DESIGN AND METHODOLOGY 
 
STUDY DESIGN: 
 
 Quasi Experimental Study Design 
 
STUDY SETTING: 
 
 Hospital approved by the guide and college. 
 
SAMPLING: 
 
 Purposive Random Sampling. 
 40 patients who were diagnosed for COPD were selected and 
divided into 2 groups alternatively after taking written consent to 
participate in the study. Participants in group ‘A’ received Autogenic 
Drainage and participants in Group ‘B’ received Postural Drainage by 
the same investigator twice a day for 10 days continuously. 
 
INCLUSION CRITERIA: 
 
1. Male patients diagnosed as COPD. 
2. Age group between 30 – 50 years. 
3. Capable to follow verbal & written commands. 
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EXCLUSION CRITERIA: 
1. Restrictive lung disease (Lung abscess, Tuberculosis). 
2. Patients having any site of active infection (e.g. Tuberculosis, 
Lung abscess), Emphyema. 
3. Thoracic surgery 
4. Patients who have taken any prior physiotherapy treatment for 
respiratory problems. 
5. Multiple respiratory & cardiac disorders. 
6. Emphysematous cavity. 
7. Recent Head injury 
8. Resting BP below 110/70 or above 130/80. 
 
MATERIALS USED: 
 
1. Computerized Spirometer 
2. Postural Drainage Couch. 
3. Stop Clock. 
4. Recording Sheet. 
 
PROCEDURE 
TECHNIQUES OF SECRETION REMOVAL: 
 
 Each patient was explained well about the procedure to be done 
and its effects following which autogenic drainage and postural 
drainage were given to group A and group B respectively. 
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 Prior to beginning with the treatment session for both groups, 
pulmonary function tests were performed to determine the values of  
 
 Forced Vital Capacity (FVC). 
 Forced Expiratory Volume in one second (FEV1). 
 Ratio of Forced Expiratory Volume in one second and Forced 
Vital Capacity (FEV1/FVC). 
 Inspiratory Reserve Volume (IRV). 
 Expiratory Reserve Volume (ERV). 
 Tidal Volume (TV). 
for each patient were recorded. 
 
AUTOGENIC DRAINAGE: 
 
 Patients of Group A were given autogenic drainage which 
comprise of 3 phases, which can be explained as follows –  
 
PHASE I: (Unsticking Phase) 
 
 Patients were asked to inspire which was followed by a deep 
expiration into ERV as much as possible contracting the abdominal 
muscles to achieve this. This low lung volume breathing was continued 
until the mucous loosened and started moving to the larger airways. 
 
PHASE II: (Collecting Phase) 
 
 Patients were asked to perform a inspiration which was held for 
1 – 3 seconds followed by expiration. This low to mid – lung volume 
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breathing was continued until the sound of mucous decrease indicating 
its movement into the central airways. 
 
PHASE III: (Evacuating Phase) 
 
Patient was asked to perform a long inspiration into the IRV 
range holding it for 1 – 3 seconds and then expiring. This was 
continued until the secretions moved into the trachea and was ready to 
be expectorated. The collected mucous was then evacuated by a 
stronger expiration or a high volume huff. 
 
 In all of the above phases, inhalation was done slowly and 
through nose if possible using the diaphragm and lower chest. The 2 – 
3 second hold which followed inspiration was included to allow 
collateral ventilation to get air behind the secretion. Exhalation was 
asked to be performed through the mouth, through open glottis so that 
the secretion could be heard. Each level requiring about an average of 
2 – 3 minutes with a full cycle being completed in about 6 – 10 
minutes. Coughing was avoided in Phase I & Phase II. 
 
 During this procedure it was ensured that all patients develop a 
personal technique based on their own capability and state of health. 
 
POSTURAL DRAINAGE: 
 
 Patients in Group B were given postural drainage which 
involved positioning the patient in a way so that gravity assists the 
drainage of the affected lung segments. 
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 Each patient was auscultated following which they were placed 
in the appropriate position using pillows or bed rolls as needed to drain 
the affected lung segment or lobe. These positions were maintained for 
20 – 30 minutes. 
 
 The tables and diagrams below show the position the patient had 
to be placed in to drain the respective lung segment. 
 
 
UPPER LOBE: 
 Apical Segments (Rt)  
o Patient seated upright. 
 
 
Fig. 4.1 
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 Posterior segment (Rt) 
o Patient should lie on left side then turn 450 on to his face 
resting against a pillow with other supporting his head. 
 
 
 
Fig. 4.2 
 
 Posterior segment (Lt) 
 
o Patient should lie on his right side then turn 450 on to his 
face with 3 pillows arranged to raise the shoulder 30 cm 
from bed. 
 
 
Fig. 4.3 
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 Anterior segment (Rt & Lt) 
 
o Patient should lie flat on his back with arms by his side 
and knee is flexed over pillow. 
 
 
Fig. 4.4  
 
MIDDLE LOBE: 
 
 Right lung : Lateral & Medial Segment: 
o Patient lie on his back with body quarter turn to the left 
with pillows below right side from shoulder to hip and 
foot end of bed raised 14” from ground. 
 
 
Fig. 4.5 
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 Left Lung: Superior & Inferior Segment: 
o Patient lie on his back with body quarter turn to right with 
pillows below. Left side from shoulder to hip and foot end 
of bed raise 14” from ground. 
 
 
 
Fig. 4.6 
 
LOWER LOBE: 
 
 Apical segment (Rt & Lt): 
o Patient lying prone with head turned to one side. 
 
 
Fig. 4.7 
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 Anterior basal Segment (Rt & Lt): 
 
o Patient lying flat on his back with buttock resting on a 
pillow and knees bend, foot end of bed raised 18” from 
the ground. 
 
 
Fig. 4.8 
 
 Posterior Segment (Rt & Lt): 
 
o Patient lying prone with pillow under hips. Foot end of 
bed raised 18” from ground. 
 
 
Fig. 4.9 
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 Medial basal segment (Rt): 
 
o Patient lying on the right side. Foot end of bed raised 18” 
from the ground. 
 
Fig. 4.10 
 
 Lateral basal segment (Rt & Lt): 
 
o Patients should lie on the opposite side to be drained with 
foot end of the bed raised 18” from the ground.4 
 
 
Fig. 4.11 
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Patients of both groups were given their respective treatment for 
10 days twice a day and at the end of 10 days PFT was repeated and 
parameters were recorded for evaluation. 
 
PULMONARY FUNCTION TESTS (PFT): 
 
 PFT determines the work capacity of the lungs. The test reveals 
the capacity of air it can hold, speed of breathing and ability to 
exchange gases from blood. The test can diagnose lung diseases and 
measure the severity of lung problems. 
 
 Spirometer measures the speed of air that can move in and out of 
the lungs. For this test breathing is done through a mouth piece 
attached to a recording device (spirometer). The information collected 
will be printed out on a chart called a spirogram. 
 
Lung function tests are done to  
 Determine the cause of breathing problems. 
 Diagnose certain lung diseases, such as COPD, restrictive 
diseases. 
 Evaluate a person’s lung function before surgery. 
 Monitor the effectiveness of treatment for lung diseases.14 
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The common lung function values measured with Spirometry are 
 
 Forced Vital Capacity (FVC): 
o Forcefully exhaled after a deep inhalation. 
o VC =  4700 ml (4.7 lit) 
 Inspiratory Reserve Volume (IRV): 
o Volume of air inspired forcefully beyond TV. 
o IRV = 3000 ml (3 lit) 
 Tidal Volume (TV): 
o Volume of air breathed in a single normal quiet 
respiration 
o TV = 500 ml (0.5 lit) 
 Expiratory Reserve Volume (ERV): 
o Volume of air expired forcefully after normal expiration 
o ERV = 1200 ml (1.2 lit) 
 Force Expiratory Volume (FEV): 
o Volume of air expired forcefully in a given unit of time 
(after a deep inspiration) 
 FEV1: 
o Amount of air expired forcefully in 1 sec. 
o FEV1 = 75% of total VC.15 
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Table 4.1: Variations of PFT values in COPD 
 
Lung Function Test14 Result as predicted for age, 
height, weight. 
Forced Vital Capacity (FVC) Normal or lower than predicted 
value 
Forced Expiratory Volume 
(FEV1) 
Lower with higher FEV2 and FEV3 
FEV1 divided by FVC Lower 
Forced Expiratory flow 25% to 
75% 
Lower 
Peak Expiratory flow (PEF) Lower 
Maximum voluntary ventilation 
(MVV) 
Lower 
Slow Vital Capacity (SVC) Normal or Lower 
Total Lung Capacity (TLC) (VT) Normal or higher 
Functional residual capacity 
(FRC) 
Higher 
Residual Volume (RV) Higher 
Expiratory Reserve Volume 
(ERV) 
Normal or Lower 
RV divided by TLC ratio Higher 
 
In COPD, when patients perform a VC maneuver, it can either 
be slow or fast. During exhalation, the amount of air exhaled over time 
can be measured. In a slow VC a patient with COPD can take a great 
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deal of time to empty his lungs. In a FVC a normal individual can 
exhale 75% of the VC in 1st sec of exhaled (FEV1). Patients with 
COPD often have a greatly decreased VCs. Only 40% of which are 
predicted. A decreased in VC occurs as a result of absolute reduction in 
distensible lung tissue.16 
 
Table 4.2: Variations of PFT values in Restrictive Lung Diseases 
 
Lung Function Test14 Result as predicted for age, 
height, weight. 
Forced Vital Capacity (FVC) Lower than predicted value 
Forced Expiratory Volume 
(FEV1) 
Normal or lower with higher FEV2 
and FEV3 
FEV1 divided by FVC Normal or higher 
Forced Expiratory flow 25% to 
75% 
Normal or Lower 
Peak Expiratory flow (PEF) Normal or higher 
Maximum voluntary ventilation 
(MVV) 
Normal or Lower 
Slow Vital Capacity (SVC) Lower 
Total Lung Capacity (TLC) (VT) Lower 
Functional residual capacity 
(FRC) 
Normal or Higher 
Residual Volume (RV) Normal or Higher 
Expiratory Reserve Volume 
(ERV) 
Normal or Lower 
RV divided by TLC ratio Normal or Higher 
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 In Restrictive lung conditions, there is a loss of lung tissue, a 
decrease in the lung’s ability to expand, or a decrease in the lung’s 
ability to transfer oxygen to the blood or carbon dioxide out of the 
blood. Restrictive lung disease can be caused by conditions such as 
pneumonia, lung cancer, scleroderma, pulmonary fibrosis, sarcodosis 
or multiple sclerosis. Other restrictive conditions include some chest 
injuries, being very overweight (Obesity), pregnancy, and loss of lung 
tissue due to surgery.14 
  
PICTURE 4.13: 
 
PATIENT PERFORMING AUTOGENIC DRAINAGE 
 
 
Picture: 4.14 
 
 
PATIENT PERFORMING PFT TEST 
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PATIENT PERFORMING PFT TEST 
 
PICTURE: 4.15 
 
 
PATIENT PERFORMING POSTURAL DRAINAGE 
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DATA ANALYSIS 
 
The collected data were tabulated and analyzed using descriptive 
and inferential statistics to assess all the parameters. The mean and 
standard deviation was used to find out the effectiveness of Autogenic 
Drainage and Postural Drainage from 1st day of treatment to 10th day of 
treatment. 
 
 Data of pre and post treatment parameters were recorded as 
previously described in the procedure. 
 Arithmetic Mean and Standard Deviation were calculated for 
each variable (series of reading). 
 Arithmetic Mean was derived from adding all the score together 
and dividing the total by the number of scores. 
 Standard Deviation (SD) was calculated by following formula 
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SD is the average amount of deviation and is computed by 
taking the square root of the variance score. The deviation provides 
information about the extent to which each score deviates from the 
mean. 
 
Paired ‘t’ tests were used to determine differences between pre and 
post treatment of the intra group. 
                ∑ d  
t = 
 n ∑ d2 2 
  
 
Where, √ = square root of the final calculation of everything 
under the Square root sign. 
 
 ∑d  = total of the difference. 
       (∑d)2 = total of the differences, squared. 
 ∑d2  = total of the squared differences 
   N  = No. subjects or pairs of matched subjects. 
   P  = < 0.05 was taken as significant. 
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Unpaired ‘t’ tests were used to determine difference between pre and 
post treatment of the intergroup. 
 
                                                        X1   2                     
t   =  
                ∑X12 12)   + ∑X22    22)      
                                      n1                                                       n1              1               1 
 *              n1     +  n2      
                                         (n1 - 1)+ (n2 – 1) 
 
 Where,  
 
X1 = mean of scores from condition 1. 
 
X2 = mean of scores from conditions 2. 
 
∑X12 = square of each individual score from condition 1  
    totally. 
 
∑X22 = square of each individual score from condition 2  
    totally. 
 
(∑X1)2= the total of the individual scores from condition 1  
     scored. 
 
        (∑X2)2= the total of the individual scores from condition 2  
    scored. 
 
 n1 = number of subjects in condition 1. 
 n2 = number of subjects in condition 2. 
 P  = < 0.05 was taken as significant. 
 
  
 
 29 
AUTOGENIC DRAINAGE: (Group A) 
TABLE. 5.1  
Mean and SD changes of pre and post treatment in FVC in  
Group A 
 
GROUP A N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 2.574 0.3464  
t = 0.101 
 
p = 0.920 
POST 20 2.566 0.3557 
DIFF  0.0075 0.3316 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of FVC in group A with t = 0.101. 
 
Graph:  5.1 
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Table 5.2:  
 
Mean and SD changes of pre and post treatment in FEV1 
 
GROUP A N MEAN 
(litres) 
SD ‘t’ values ‘p’ values 
PRE 20 1.551 0.3309  
t = 1. 319 
 
p = 0.203 POST 20 1.678 0.3464 
DIFF  0.127 0.4306 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of FEV1 in group A with t = 1. 319. 
 
Graph: 5.2 
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Table: 5.3  
Mean and SD changes of pre and post treatment in FEV1 / FVC 
 
GROUP A N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 58.1 11.16  
 
‘t’ = 6.269 
 
 
 
p = 0.000 
 
POST 20 65.51 10.21 
DIFF  7.414 5.289 
 
The FEV1 / FVC changes in pre and post treatment is highly significant 
(p = 0.000) with t = 6.269. 
 
Graph: 5.3 
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Table 5.4  
Mean and SD changes of pre and post treatment in ERV 
 
GROUP A N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 0.596 0.4224  
 
‘t’ = 0.718 
 
p = 0.482 
 
POST 20 0.4825 0.4509 
DIFF  0.1135 0.7072 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of ERV in group A with t = 0.718. 
 
Graph: 5.4. 
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Table 5.5:  
Mean and SD changes of pre and post treatment in IRV 
 
GROUP A N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 0.7695 0.374  
 
‘t’ = 0.865 
 
 
P = 0.162 
 
POST 20 0.8555 0.2511 
DIFF  0.086 0.4447 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of IRV in group A with t = 0.865. 
 
Graph: 5.5 
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Table 5.6:  
Mean and SD changes of pre and post treatment in TV 
 
GROUP A N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 0.7045 0.2925  
 
‘t’ = 1.456 
 
 
p = 0.162 
 
POST 20 0.5895 0.4121 
DIFF  0.115 0.3532 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of TV in group A with t = 1.456. 
 
Graph: 5.6 
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POSTURAL DRAINAGE (GROUP B) 
Table 5.7:  
Mean and SD changes in Pre an Post Treatment in FVC 
 
GROUP B N   MEAN 
   (Litres) 
SD ‘t’ value ‘p’ value 
PRE 20 2.43 0.2445  
‘t’ = 1.959 
 
p = 0.065 
 
POST 20 2.301 0.2625 
DIFF  0.129 0.2945 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of FVC in group B with t = 1.959. 
 
Graph: 5.7 
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Table 5.8:  
Mean and SD changes of Pre and Post treatment in FEV1 
 
GROUP B N MEAN 
(Litres) 
SD ‘t’ value ‘p’ value 
PRE 20 1.51 0.2804  
 
‘t’ = 1.139 
 
 
p = 0.269 
 
POST 20 1.471 0.2881 
DIFF  0.03895 0.153 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of FEV1 in group B with t = 1.139. 
 
Graph: 5.8 
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Table 5.9:  
Mean and SD changes of Pre and Post treatment in FEV1 / FVC 
 
GROUP B N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 62.39 11.46  
 
‘t’ = 1.586 
 
 
p = 0.129 
 
POST 20 63.98 11.29 
DIFF  1.592  4.49 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of FEV1/FVC in group B with t = 1.586. 
 
Graph: 5.9 
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Table 5.10:  
Mean and SD changes of Pre and Post treatment in ERV 
 
GROUP B N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 0.448 0.3744  
t = 0.245 
 
p = 0.809 
 
POST 20 0.4235 0.431 
DIFF  0.0245 0.4469 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of ERV in group B with t = 0.245. 
 
Graph: 5.10 
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Table 5.11:  
Mean and SD changes of pre and post treatment in IRV 
 
GROUP B N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 0.8145 0.3396  
‘t’ = 0.586 
 
p  = 0.565 
 
POST 20 0.758 0.32 
DIFF  0.565 0.4315 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of IRV in group B with t = 0.586. 
 
Graph: 5.11 
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Table 5.12:  
Mean and SD changes of pre and post treatment in TV 
 
GROUP B N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
PRE 20 0.5625 0.3152  
‘t’ = 0.670 
 
p = 0.511 
 
POST 20 0.634 0.4284 
DIFF  0.0715 0.4774 
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of TV in group B with t = 0.670. 
 
Graph: 5.12 
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COMPARISSION BETWEEN  
POSTURAL DRAINAGE Vs AUTOGENIC DRAINAGE 
Table 5.13:  
Mean and SD changes of AD and PD in FVC 
 
GROUP N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
AD 20 0.129 0.1964  
‘t’ = 1.410 
 
p = 0.167 
 
PD 20 0.0075 0.3316 
DIFF  0.1215   
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of FVC in group B with t = 1.410. 
Graph: 5.13 
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Table 5.14:  
Mean and SD changes of AD and PD in FEV1 
 
GROUP N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
AD 20 0.039 0.153  
‘t’ = 1.726 
 
p = 0.093 
 
PD 20 0.115 0.3588 
DIFF  0.1505   
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of FEV1 in group B with t = 1.726. 
 
Graph: 5.14 
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Table 5.15:  
Mean and SD changes of AD and PD in FEV1 / FVC 
 
GROUP N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
AD 20 1.592 3.159 ‘t’ = 3.044 P = 0.004 
 
PD 20 16.46 21.61 
DIFF  14.87   
 
The FEV1 / FVC changes in pre and post treatment is highly significant 
(p = 0.000) with t = 3.044. 
 
Graph: 5.15. 
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Table 5.16:  
Mean and SD changes of AD and PD in ERV 
 
GROUP N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
AD 20 0.0245 0.455  
‘t’ = 0.530 
 
p = 0.599 
 
PD 20 0.1135 0.5972 
DIFF  0.089   
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of ERV in group B with t = 0.530. 
 
Graph: 5.16 
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Table 5.17:  
Mean and SD changes of AD and PD in IRV 
 
GROUP N MEAN 
(litres) 
SD ‘t’ value ‘p’ value 
AD 20 0.053 0.3597  
‘t’ = 1.074 
 
p = 0.290 
 
PD 20 0.086 0.4535 
DIFF  0.139   
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of IRV in group B with t = 1.074. 
 
Graph: 5.17. 
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Table: 5.18  
Mean and SD changes of AD and PD in TV 
 
GROUP N MEAN 
(litres) 
SD ‘t’ value ‘p’value 
AD 20 0.0555 0.4047  
‘t’ = 1.066 
 
p = 0.293 
 
PD 20 3.039 12.98 
DIFF  3.094   
 
There was no significant change (p > 0.05) in the pre and post 
treatment values of TV in group B with t = 1.066. 
 
Graph: 5.18. 
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RESULT 
 
 
 The unpaired ‘t’ test between the pre and post treatment values 
in Group A showed no significant changes in FVC with a ‘t’= 0.101,   
p = 0.920; for FEV1 showed no significant changes with ‘t’ = 1.319,   
p = 0.203; for ERV showed no significant changes with ‘t’ = 0.718,     
p = 0.482; for IRV showed no significant changes with ‘t’ = 0.865,      
p = 0.162; for TV showed no significant changes with ‘t’ = 1.456,        
p = 0.162; for FEV1 / FVC showed high significance with ‘t’ = 6.269, 
p = 0.000. 
 The unpaired ‘t’ test between the pre and post treatment values 
in Group B showed no significant changes in FVC with a ‘t’= 1.959,   
p = 0.065; for FEV1 showed no significant changes with ‘t’ = 1.139,   
p = 0.269; for ERV showed no significant changes with ‘t’ = 0.245,     
p = 0.809; for IRV showed no significant changes with ‘t’ = 0.586,      
p = 0.565; for TV showed no significant changes with ‘t’ = 0.670,        
p = 0.511; for FEV1 / FVC showed no significance with ‘t’ = 1.586,    
p = 0.129. 
 When unpaired ‘t’ test was used to determine difference between 
pre and post treatment values of the intergroup showed no significant 
changes in FVC with a ‘t’= 1.410, p = 0.167; for FEV1 showed no 
significant changes with ‘t’ = 1.726, p = 0.093; for ERV showed no 
significant changes with ‘t’ = 0.530, p = 0.599; for IRV showed no 
significant changes with ‘t’ = 1.074, p = 0.290; for TV showed no 
significant changes with ‘t’ = 1.066, p = 0.293; for FEV1 / FVC 
showed high significance with ‘t’ = 3.044, p = 0.004.  
  
 48 
DISCUSSION 
 
 Many studies have investigated the effects of bronchial drainage 
techniques on pulmonary function and reported that conventional 
physiotherapy methods or a combination of different techniques could 
maintain or improve the pulmonary function test parameters including 
FEV1/FVC, ERV, and IRV. 
 
 Leister et al.,17 studied a two separate groups of cystic fibrosis 
patients for a period of 14 days.  Group I patients were treated 
preferentially with AD in combination of a positive expiratory pressure 
mask.  In Group II individualized treatment procedures were used as 
preferred by the patients.  They found that pulmonary function tests 
and SaO2 improved significantly after both treatments.  In my study 
FVC, FEV1, FEV1/FVC. ERV, IRV, TV after PD does not show any 
significance (P > 0.05) but FEVI / FVC improved significantly            
(P < 0.05). 
 
 In this study, it includes a three phase breathing exercise.  The 
gradually increasing Inspiratory and expiratory reserve volumes from 
functional residual capacity and a 2 to 3 sec. breath holding period 
resulted in collateral filling among the alveoli and improved ventilation 
and mobilized secretions.  PD consists of adopting a position in which 
the lobe to be drained is uppermost, thereby allowing secretions in the 
dilated bronchi to gravitate towards the teacher, from which they can 
readily be cleaned by vigorous coughing.  Giles et al18 stated that AD is 
related to mucus clearing.  In addition, positioning given in PD is 
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designed to improve the mobilization of bronchial secretions aid to 
normalize functional residual capacity based on the effects of gravity.  
It is noted that AD and OD used in this study improve lung function by 
ensuring collateral vent in segments of lung. 
 
 In this study no statistical significant improvement was found in 
FVC, FEV1, ERV, IRV and TV in both groups except FEV1/FVC in 
AD. No statistical significance is probably because of less number of 
data.  But clinically noticeable improvement in all the parameters was 
seen in both the groups. Probably it may be because both the 
techniques are effective in mucus clearance but it is also noticed that 
AD is more effective than PD because in AD patient is asked not do 
nonproductive coughing which can cause collapse of the airways 
whereas in PD no such instructions are given to the patient. 
 
 Donald R Giles18 investigated the effects of AD and PD in cystic 
fibrosis.  Ten patients were diagnosed as having cystic fibrosis and 
each patient received both AD and PD on separate days.  He found that 
both AD and PD have similar effects in patients and mucus clearance 
has similar.  Although, both techniques AD and PD improved 
clinically the increase in AD group was significantly higher than in PD 
groups.  This could be probably because of a larger airflow without an 
airway collapse and better co-operation requirements between the 
patient and the physiotherapist in AD technology.  A conditions 
auditory feedback was given to the patient during the application of 
AD treatment. 
 50 
CONCLUSION 
 
 The study reveals that both AD and PD are effective techniques 
in the clearance of mucus which is one of the causes of airway 
obstruction in patients with COPD as shown in pulmonary function 
test. Although AD technique was more difficult for patients to learn, 
but once the patients used the techniques correctly it was found to be 
effective. The PFT values have improved in both the groups with a 
good FEV1 / FVC ration through AD techniques which is suggestive 
of an improved airway entry which is quite possible with a clear lung, 
and thus by reducing the dead space. However the patient’s 
compatibility has to be kept into consideration. 
 
 As it is evident that both the techniques were effective it can be 
said that no single technique is better than the other. So an individual 
adjustment of a specific technique has to be determined for every 
patient. General rules can not be given but guidelines can be suggested 
to adjust the technique towards the need of the patient. the best 
treatment technique for any patient is the one which the patients feels 
most comfortable, which he is able to continue, which provides larger 
mucus clearance and which maintains acceptable health according to 
the stage of disease. 
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LIMITATIONS 
 
 This study was evident to prove an improvement in PFT values 
in both the groups but still the functional capabilities of the patients 
were unknown. This could have been identified if the O2 saturation 
level and the sputum measurements were done to identify their 
efficiency and ability of functional activities. 
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APPENDICES 
 
APPENDIX 1–CONCENT FORM 
 
          Date: 
You are requested to be a part of this research study, which is part of the 
curriculum for the course of MPT run by the DR. MGR University of Health 
Sciences. To identify an effective technique for airway clearance and to improve 
pulmonary function. Your participation will consist essentially of attending daily 
for 10 days each session approximately for 30 minutes. You will be either 
treated with autogenic drainage or postural drainage. This exercise will not 
cause any harm to you.  
 
Permission for this study has been acquired from the hospital authorities. We 
will clarify any of your queries regarding the study. Your identity will remain 
confidential. You are free to leave this study at any time. You are requested to 
sign this consent form. 
 
Sign _________________________ 
 
 
I voluntarily agree to participate in this research study. I am fully aware of the 
procedure that will be carried. 
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ASSESSMENT CHART 
 
1. NAME      : 
 
2. AGE      : 
 
3. SEX      : 
  
4. ADDRESS     : 
 
5. OCCUPATION     : 
 
6. CHIEF COMPLAINTS   : 
 
 
 
7. HOPI (SYMPTOMS)    : 
 
a) Dysponea: 
i. Duation    : 
ii. Onset     : Sudden / Gradual 
iii. On Exertion    : Increase / Normal 
iv. Aggravating factors  : 
v. Relieving factors   : 
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b) Cough: 
i. Duration    : 
ii. Onset     : Sudden / gradual 
iii. Type     : Productive / Non-
productive 
 
c) Expectoration 
i. Quantity / day   : 
ii. Quality    : 
iii. Colour    : 
iv. Odour    : 
 
d) Chest Pain     : Present / Absent 
e) Oedema     : Pittable / Non-pittable. 
f) Haemoptasis    : Present / Absent 
g) Fever      : Present / Absent 
h) Allergy     : Present / Absent 
 
8. Past History: 
 H/O similar complaints    : Present / Absent 
 H/O similar episodes in same season : Present / Absent 
 
9. Past Medical History  : Heart attack / High BP / 
DM / TB 
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10. Personal History 
 Smoking     : Cigarette / Bidi /  
   Tobbaco 
 Frequency / Day   : 
 Alcoholism    : Yes / No 
 
11. Family History : Present / Absent / Not 
significant. 
 
 
PHYSICAL EXAMINATION 
 
A) General Exam 
 
1. Vital signs: 
a. Temperature   : Normal / High 
b. Pulse rate    : 
c. RR     : 
d. BP     : 
 
2. Built      : Weak / Average / Obese 
3. Nutrition     : Poor / Moderate / Good 
4. Pallor      : Present / Absent 
5. Lymphadenopathy    : Present / Absent 
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Clubbing     : Present / Absent 
1. Grade 1 
2. Grade 2 
3. Grade 3 
4. Grade 4 
B) Examination of Respiratory System 
1. Inspection: 
a. Shape of Chest   : 
b. Respiratory Movements: 
i. Respiratory Rate  : (Normal / Increased / 
Decreased) 
ii. Respiratory Rhythm : (Regulatory / Irregular) 
iii. Equality   : (Equal / Unequal) 
c. Type of Breathing   : 
d. I : E Ratio    : 
e. Use of accessory muscle  : (Present / Absent) 
 
2. Palpation: 
a. Tracheal shift   : 
b. Apex beat    : Palpable / Not palpable 
c. TVF     : (Equal / Increased / 
Decreased) 
d. Chest Expansion 
i. Supra Mammary  : 
ii. Mammary   : 
iii. Infra Mammary  : 
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3. Percussion 
a. (Impaired / Stony Dill / Dull / Tympanic / Resonant / 
Hyper resonant) 
 
4. Auscultation: 
a. Breath sound: (Vesicular / bronchial / Bronchio-
Vesicular) 
b. Additional sounds: (Rales / Ronchi / Stridor / Rub) 
c. Vocal resonance: (Normal / Absent / Increased) 
 
5. Investigation 
a. Chest X – ray    : 
b. Pulmonary Function Test  :   
  
Measure Day 1 
(Pre-treatment) 
Day 10 
(Post-treatment) 
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MASTER CHART: Autogenic Drainage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.no  Age Pre Treatment Post treatment 
FVC FEV1 FEV1/FVC ERV IRV TV FVC FEV1 FEV1/FVC ERV IRV TV 
1 50 02.51 02.32 35.06 00.20 01.54 00.42 02.65 01.24 46.79 01.59 00.79 00.33 
2 50 03.17 01.66 50.76 01.62 01.33 00.82 03.12 02.04 65.38 00.21 00.76 00.72 
3 45 02.36 001.19 50.42 00.28 00.87 00.33 02.39 01.17 48.95 00.04 01.26 00.07 
4 50 02.93 02.20 75.09 00.45 00.01 00.77 03.36 02.69 80.06 00.77 00.59 00.39 
5 48 02.42 01.76 72.73 01.11 00.53 00.46 01.97 01.58 80.20 00.56 01.02 00.50 
6 55 02.67 01.18 44.19 00.55 00.50 00.65 02.54 01.43 56.30 00.08 00.95 00.45 
7 50 02.28 01.07 49.63 00.37 00.21 00.85 02.52 01.30 51.50 00.59 01.17 00.52 
8 49 02.41 01.37 56.85 00.97 01.42 00.61 02.16 01.68 77.78 00.25 00.80 00.38 
9 50 02.10 01.57 74.76 00.41 00.72 00.29 02.12 01.67 78.77 01.37 00.70 00.63 
10 40 03.29 01.50 45.59 00.61 00.95 00.77 02.82 01.59 56.38 00.15 01.00 00.05 
11 48 02.36 01.60 67.80 00.71 00.91 00.41 02.55 01.88 73.73 00.80 00.89 00.50 
12 40 02.82 01.83 64.89 00.39 00.67 00.45 02.76 01.83 66.30 00.46 00.39 00.50 
13 50 02.14 01.15 53.74 00.16 00.76 01.21 03.01 01.85 61.46 00.10 00.15 01.80 
14 39 02.96 01.54 60.16 00.47 00.67 00.81 02.55 01.74 68.24 00.23 00.69 01.50 
15 50 02.41 01.15 47.72 00.15 01.08 00.40 02.05 01.18 57.56 00.07 01.17 00.02 
16 49 02.63 01.60 60.84 00.32 00.64 00.90 02.76 01.91 69.20 00.43 00.75 00.48 
17 45 02.50 01.65 66.00 01.46 00.60 01.35 02.52 01.73 68.65 01.15 00.80 00.62 
16 46 02.06 01.42 68.93 00.89 00.77 01.08 02.42 01.77 73.14 00.17 00.95 00.71 
19 40 02.92 01.76 60.27 00.15 00.72 00.69 02.72 01.78 65.44 00.13 00.65 00.93 
20 44 02.53 01.50 59.29 00.65 00.49 00.82 02.33 01.50 64.38 00.50 01.13 01.14 
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PRE TREATMENT 
 
 
 FVC FEV1 FEV1/FVC ERV IRV TV 
Mean 2.5735 1.551 58.101 0.596 0.7695 0.7045 
SD 0.346445 0.33093 11.15629 0.422392 0.374032 0.2927272 
 
 
 
POST TREATMENT 
 
 
 
 FVC FEV1 FEV1/FVC ERV IRV TV 
Mean 2.566 1.92 65.515 0.48 0.8555 0.5895 
SD 0.355682 0.346359 10.20511 0.449374 0.251071 0.412125 
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Postural Drainage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Age Pre Treatment Post treatment 
FVC FEV1 FEV1/FVC ERV IRV TV FVC FEV1 FEV1/FVC ERV IRV TV 
1 50 02.20 01.65 75.00 00.82 00.67 00.62 02.07 01.60 77.29 00.15 00.33 00.85 
2 45 02.47 01.63 65.99 00.49 00.64 00.73 02.46 01.72 69.92 00.87 00.45 00.80 
3 48 02.43 00.76 31.28 00.61 00.93 01.16 02.55 00.84 32.94 00.26 00.72 00.77 
4 40 02.44 01.47 60.25 00.02 01.33 00.04 02.18 01.43 65.60 00.54 01.15 01.11 
5 35 02.69 01.30 48.33 00.72 00.43 00.42 02.37 01.31 55.27 00.56 01.50 00.07 
6 50 02.67 01.65 61.80 00.15 01.13 00.42 02.41 01.50 62.24 00.22 00.85 00.08 
7 45 01.72 01.21 70.35 01.10 01.51 00.93 01.78 01.29 72.47 00.15 00.96 00.01 
8 47 02.23 01.73 77.58 00.08 00.38 00.54 01.97 01.40 71.07 00.06 00.80 00.57 
9 46 02.42 01.63 67.36 00.36 00.98 00.41 01.98 01.33 67.17 00.33 00.98 00.11 
10 50 02.18 01.24 56.88 00.41 00.86 00.37 02.02 01.11 54.95 00.05 00.76 00.44 
11 49 02.27 00.99 43.61 00.05 00.56 00.02 02.14 00.99 43.61 00.05 00.56 00.02 
12 48 02.83 01.63 57.60 01.09 01.00 00.51 02.18 01.31 60.09 01.89 00.84 00.64 
13 40 02.33 01.70 72.96 00.14 00.27 00.83 02.33 01.81 77.68 00.61 00.64 01.02 
14 39 02.46 01.58 64.23 00.56 00.67 00.50 02.40 01.46 60.83 00.85 00.84 00.48 
15 47 02.42 01.67 69.01 00.09 00.93 00.89 02.26 01.59 70.35 00.11 00.97 00.86 
16 50 02.69 01.85 68.77 00.24 00.35 00.85 02.79 01.98 70.97 00.19 00.33 01.29 
17 48 02.47 01.50 60.73 00.29 00.80 00.85 02.55 01.65 64.71 00.37 00.57 01.00 
18 35 02.53 01.64 64.82 00.22 00.89 00.67 02.59 01.31 69.88 00.67 00.57 00.92 
19 43 02.70 01.50 55.56 00.28 00.66 00.92 02.67 01.51 56.55 00.15 00.18 01.33 
20 50 02.46 01.86 75.61 01.24 01.30 00.07 02.33 01.77 75.97 00.39 01.16 00.31 
 65 
PRE TREATMENT 
 
 
 FVC FEV1 FEV1/FVC ERV IRV TV 
Mean 2.4305 1.5095 62.386 0.423 0.758 0.634 
SD 0.244529 0.280422 11.46373 0.331648 0.319961 0.428355 
 
 
POST TREATMENT 
 
 
 FVC FEV1 FEV1/FVC ERV IRV TV 
Mean 2.3015 1.4705 1.31 0.4235 0.758 0.634 
SD 0.262524 0.288069 11.29259 0.430963 0.319961 0.428355 
 
